1. Home
  2. Material Detail: Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? - PubMed

Material Detail

Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? - PubMed

Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? - PubMed

The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people and caused tremendous morbidity and mortality worldwide. Effective treatment for coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 infection is lacking, and different therapeutic strata are needed.

Keywords:
vaccine, COVID-19
Disciplines:
Go to Material 
Bookmark / Add to Course ePortfolio
Create a Learning Exercise
Add Accessibility Information
Rate
Add a Comment

Quality

  • Editor Reviews
  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Material Type:
Reference Material
Date Added to MERLOT:
August 17, 2021
Date Modified in MERLOT:
August 17, 2021
Author:
Unknown (Know the author?)
Submitter:
Mary Bemker
Primary Audience:
College Lower Division, College Upper Division, Graduate School, Professional
Technical Format:
Website
Mobile Compatibility:
Not specified at this time
Technical Requirements:
Aaccessed via Google Chrome.
Language:
English
Cost Involved:
No
Source Code Available:
Yes
Accessibility Information Available:
Unknown
Creative Commons:
Unknown

Browse...

Disciplines with similar materials as Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? - PubMed
People who viewed this also viewed
Other materials like Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? - PubMed

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.